Abeona therapeutics announces first patient treated in pivotal phase iii clinical trial evaluating eb-101 gene therapy for recessive dystrophic epidermolysis bullosa

Majority of potential study participants have been pre-screened

ABEO Ratings Summary

ABEO Quant Ranking